Stockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) performing ASX small caps in morning trade using live data.

It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms.

The market opens at 10am (eastern time) and the data is taken at 10:15am, once every ASX stock has commenced trading.

Stocks highlighted in yellow have made market-moving announcements (click headings to sort).

 

Code Company Price % Volume
ANL Amani Gold Ltd 0.002 100 3825000
HYD Hydrix Limited 0.24 55 2881400
CLZ Classic Min Ltd 0.0015 50 13912550
AT1 Atomo Diagnostics 0.2 48 7342209
ECT Env Clean Tech Ltd. 0.002 33 1650871
DCX Discovex Res Ltd 0.006 20 1593155
YOJ Yojee Limited 0.16 19 1369592
GES Genesis Resources 0.015 15 485000
NMR Native Mineral Res 0.31 15 83450
NUS Nusantara Resources 0.345 13 219230

Atomo Diagnostics (ASX:AT1) had a jointly developed COVID-19 test approved by the FDA.

Hydrix (ASX:HYD) also got FDA approval for its medical device, namely the heart monitoring device AngelMed Guardian.

In resources, Indonesia focused gold play Nusantara Resources (ASX:NUS) got a takeover offer.

 

Code Company Price % Volume
CYC Cyclopharm Limited 1.8 -34 79246
NPM Newpeak Metals 0.0015 -25 3494000
MRD Mount Ridley Mines 0.0025 -17 5260500
MRQ Mrg Metals Limited 0.006 -14 82000
CY5 Cygnus Gold Limited 0.1 -13 83000
ADV Ardiden Ltd 0.008 -11 2112712
IVT Inventis Limited 0.008 -11 500000
PNX PNX Metals Limited 0.008 -11 499000
MCT Metalicity Limited 0.009 -10 140000
ASO Aston Minerals Ltd 0.155 -9 263504

Cyclopharm (ASX:CYC) however got the cold shoulder from the FDA in relation to Technegas – its radioactive lung imaging agent.